XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Summary of net income (loss) attributable to Archrock common stockholders used in the calculation of basic and diluted income (loss) per common share

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

Net income (loss)

$

9,304

$

18,332

$

22,225

$

(73,236)

Less: Earnings attributable to participating securities

 

(456)

 

(439)

 

(909)

 

(1,083)

Net income (loss) attributable to common stockholders

$

8,848

$

17,893

$

21,316

$

(74,319)

Schedule of potential shares of common stock that were included in computing diluted income (loss) attributable to Archrock common stockholders per common share

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

Weighted average common shares outstanding including participating securities

154,041

152,973

153,422

152,790

Less: Weighted average participating securities outstanding

 

(1,883)

 

(1,999)

 

(1,807)

 

(2,060)

Weighted average common shares outstanding used in basic net income (loss) per common share

 

152,158

 

150,974

 

151,615

 

150,730

Net dilutive potential common shares issuable:

 

 

  

 

  

 

  

On exercise of options and vesting of performance-based restricted stock units

 

138

57

 

152

 

On settlement of ESPP shares

 

1

7

 

2

 

Weighted average common shares outstanding used in diluted net income (loss) per common share

 

152,297

 

151,038

 

151,769

 

150,730

Schedule of potential shares of common stock issuable, excluded from computation of diluted income (loss), attributable to Archrock common stockholders per common share

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

On exercise of options where exercise price is greater than average market value for the period

15

 

85

 

27

 

102

On exercise of options and vesting of performance-based restricted stock units

57

On settlement of ESPP shares

19

Net dilutive potential common shares issuable

15

85

27

178